a month ago
KYMR
AnalystsAlex ThompsonAlex Thompson's Stock Forecasts
AnalystsAlex Thompson
Sectors:
Industries:
Analyst Ranking
Top 15%
#801 out of 5548 analysts
Average Return
+19.24%
Win Rate
55%27 out of 49
Risk vs Reward
Poor
Good
Alex Thompson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | +185.79% | $37.16 | $106.20 | 2025-09-12 - 2026-09-11 | Strong Buy |
Kymera Therapeutics IncKYMR | +148.54% | $31.44 | $78.14 | 2025-05-20 - 2026-05-19 | Strong Buy |
Dice Therapeutics IncDICE2 | +126.21% | $21.02 | $47.55 | 2022-09-07 - 2023-08-08 | Strong Buy |
Oruka Therapeutics IncORKA | +125.83% | $40.00 | $90.33 | 2026-03-13 - 2026-10-26 | Strong Buy |
Spyre Therapeutics IncSYRE | +115.77% | $43.06 | $92.91 | 2026-03-18 - 2026-10-26 | Strong Buy |
Alex Thompson Analyst Color
Get additional color on Alex Thompson's coverage of popular stocks
7 months ago
SYRE
8 months ago
ORKA
8 months ago
ANAB
a year ago
ASND
a year ago
ARGX
a year ago
ANAB
a year ago
DNTH
2 years ago
ASND
2 years ago
ARGX
3 years ago
SYRE
3 years ago
SYRE
3 years ago
ACRS
3 years ago
IMVT
4 years ago
ARGX
4 years ago
KDNY
Alex Thompson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $152.00 | +32.36% | Maintains | a month ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $51.00 | +41.47% | Initiates Coverage On | a month ago |
Ascendis Pharma AASND | 5 | Strong Buy | $326.00 | +32.98% | Maintains | 2 months ago |
Spyre Therapeutics IncSYRE | 5 | Strong Buy | $107.00 | +15.17% | Maintains | 6 months ago |
Oruka Therapeutics IncORKA | 2 | Strong Buy | $72.00 | -20.29% | Maintains | 8 months ago |
Anaptysbio IncANAB | 3 | Strong Buy | $85.00 | +74.29% | Maintains | 8 months ago |
Celldex Therapeutics IncCLDX | 1 | Strong Buy | $68.00 | +130.51% | Reiterates | 8 months ago |
Alumis IncALMS | 1 | Strong Buy | $44.00 | +575.88% | Initiates Coverage On | 8 months ago |
Palisade Bio IncPALI | 1 | Strong Buy | $5.00 | +306.50% | Initiates Coverage On | 8 months ago |
Argenx SeARGX | 5 | Strong Buy | $1,248.00 | +43.56% | Maintains | a year ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Travere Therapeutics IncTVTX | 4 | Hold | $25.00 | N/A | Maintains | a year ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $22.00 | N/A | Reinstates | a year ago |
Third Harmonic Bio IncTHRD | 2 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Morphic Holding IncMORF | 4 | Hold | $57.00 | N/A | Maintains | 2 years ago |
Ventyx Biosciences IncVTYX | 5 | Hold | $2.00 | N/A | Maintains | 3 years ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Strong Buy | $69.00 | N/A | Maintains | 3 years ago |
Aclaris Therapeutics IncACRS | 4 | Hold | $1.00 | N/A | Maintains | 3 years ago |
Viridian Therapeutics IncVRDN | 2 | Strong Buy | $40.00 | N/A | Reiterates | 3 years ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 3 years ago |
Immunovant IncIMVT | 2 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $41.00 | N/A | Downgrades | 3 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 4 years ago |
Dice Therapeutics IncDICE2 | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.